Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
Novo Nordisk A/S
John Deanfield; Subodh Verma; Benjamin M Scirica; Steven E Kahn; Scott S Emerson; Donna Ryan; Ildiko Lingvay; Helen M Colhoun; Jorge Plutzky; Mikhail N Kosiborod; G Kees Hovingh; Søren Hardt-Lindberg; Ofir Frenkel; Peter E Weeke; Søren Rasmussen; Assen Goudev; Chim C Lang; Miguel Urina-Triana; Mikko Pietilä; A Michael Lincoff; SELECT Trial Investigators
Department of Biostatistics, University of Washington, Seattle, WA, USA.